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Introduction
During the years 19911997 the number of nuclear medicine (NM)
laboratories and radionuclide investigations in Ukraine decreased
significantly. The number of radioimmunoassays decreased by
2.2 times, functional radionuclide investigations fell by 4.6 times,
scans and scintigraphies fell approximately by 10 times. The num-
ber of NM laboratories decreased from 81 in 1991 to 65 in 1998.
Mainly this is related to difficulties with obtaining radiopharma-
ceuticals. Unfortunately, due to the economic difficulties in this
country, the Ukrainian Ministry of Public Health does not have suf-
ficient funds to cover the expenses of radiopharmaceuticals. To-
day, in accordance with official decisions, the Ministry of Public
Health provides funds for radiopharmaceuticals for only 7 institu-
tions. Other NM laboratories must find funds on their own using
local budgets. Unfortunately, most of them are unsuccessful in
their efforts. Moreover the limited funds for centrally-financed ra-
diopharmaceuticals (i.e. through the Ministry of Public Health)
cannot satisfy the needs of all users.
The main goals
In order to improve the situation we have tried to establish the
following goals:
1) to create a National Society of NM;
2) to create the facilities for manufacturing gamma cameras and
for providing quality control of gamma cameras;
3) to improve the situation in the supply of radiopharmaceuticals
and to study the issue of their domestic manufacture;
4) to implement cost-effective approaches and standardisation
of NM methods;
5) to prolong the duration and quality of postgraduate education;
6) to stimulate the interest of the medical community and the
authorities in NM in this country.
Results
Ukrainian Society of NM (USNM). USNM was created on June
24, 1998. During 19981999 information was collected about the
status of NM in 27 administrative regions of Ukraine. We estab-
lished direct ties with specialists «on-site», unified our needs and
started work towards improvement of the situation. We started to
enlighten the medical community on NM issues (serial reports on
TV and different meetings). In particular, we took part in special
meetings: «Radiology of the head and neck» (Odessa, 1998),
«Bone-soft tissues radiology. The physics of medical imaging»
(Kharkov, 1999), «Issues of malignant lymphomas  diagnosis
and treatment» (Chernigov, 1999), «1st Ukrainian Congress of irra-
diation therapy» (Kharkov, 1999), «Nuclear technologies in medi-
cine» (Kiev,1999).
We tried to involve specialists from other kinds of science in
the field of our activity. To-day many physicists from Kiev, Kharkov
and Uzgorod are members of our Society. This is very important
for the creation of real facilities for upgrading Ukrainian gamma
cameras and for studying the possible production of domestic
radiopharmaceuticals. These issues were discussed during the
1st Ukrainian Congress on NM in Kiev (1316 September, 1999). It
is worthy of note that this Congress was the first meeting dedicat-
ed to the «clear» problems of NM (NM in oncology, cardiology,
neurology, urology, hepatology etc.) in this country. In the future
we are going organise Ukrainian Congresses on NM on a regular
basis in conjunction with the Ministry of Public Health and physi-
cists. During our Congress we also discussed the issues of health
protection of individuals against the dangers of ionising radiation
in relation to medical exposure. This was especially important for
us because «The National Rules of Radiosafety» need consider-
able correction.
We established ties with EANM and IAEA. The support ob-
tained from them  contributed to the effectiveness of our activity.
In particular, the Regional Training Course on Preventive Mainte-
nance and Quality Control of Gamma-Camera Computer Systems
under the aegis of IAEA helped Ukrainian engineers to make de-
cisions about some important technical issues of upgrading and
quality control of gamma-cameras.
Some Ukrainian laboratories of NM also received from IAEA
Portable Imaging Processing (PIP) for planar gamma-cameras.
We have established a formal partnership between USNM and
the Ukrainian Association of Radiology (UAR) on the basis of
mutual agreement. The main aims of this agreement are the sci-
entific and clinical promotion of medical radiology including NM,
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development of patient examination algorithms and organisation
of common meetings. Following this agreement the representa-
tive of USNM (the President) has been included on the board of
UAR and must represent the interests of USNM. Previously UAR
was unable to really contribute to the development of NM in Ukraine
(it mainly satisfies the needs of ultrasonography, roentgenology,
MRI). Now we have a real chance to improve the situation in NM
using both our Society and UAR.
We stimulated the interest of the authorities (Ministry of Public
Health) in NM in this country and they assisted us in making deci-
sions about some of our problems. In particular, they helped us to
organise the 1st Ukrainian Congress on NM.
Equipment. During the last year the amount of equipment in-
creased by 7 domestic and 2 foreign gamma-cameras for SPECT.
To-day we have 40 functional gamma-cameras (among them 15
gamma-cameras for SPECT). We have started activities towards
quality control of gamma-cameras and standardisation of pro-
grams for radionuclide diagnosis according to the standards of
IAEA and using IAEA support. One of the main goals of these
activities is the introduction of quality control measures on a reg-
ular basis.
Radiopharmaceuticals. As a result of our activities in 19981999
some stabilisation in the supply of radiopharmaceuticals was
achieved. An increase was also recorded in radioiodine supplies.
To a certain degree this is associated with a marked increase in
thyroid cancer in Ukraine. Some NM laboratories began to use 89
Sr-chloride for bone metastases treatment. At the same time the
general level of radiopharmaceutical supplies still remains on the
low side and potentially could be increased by a few times. The
main barrier to this is the high price of foreign radiopharmaceuti-
cals. After contacts with representatives of foreign firms the price
of radiopharmaceuticals was decreased somewhat but this is still
not sufficient.
Domestic production of radiopharmaceuticals could be the
ideal solution to this problem (low price and government support)
and we discussed this issue together with physicists and the au-
thorities. The decision about domestic radiopharmaceutical man-
ufacturing depends on multiple factors and one of the main ones
among them is the quality of radiopharmaceuticals. This is asso-
ciated with the creation of a national laboratory to conduct the
quality control of radiopharmaceuticals. The latter is needed al-
ready to-day in order to create a barrier to prevent the influx of
low-quality radiopharmaceuticals into our country. Already to-day
we have low-quality scintigraphic images using radiopharmaceu-
ticals labelled with 99m Tc obtained from Uzbekistan but we can-
not evaluate the features of these radiopharmaceuticals on the
basis of control tests. Unfortunately, we also have no technique
for simple testing of the radiopharmaceuticals in the laboratory
during everyday practice.
We are not sure whether the attempts of our physicists to cre-
ate domestic radiopharmaceuticals of high quality will be success-
ful and therefore we are developing relationships with foreign firms
which can supply high quality radiopharmaceuticals. Even to-day
despite the economic difficulties our colleagues more often use
expensive but high quality radiopharmaceuticals than inexpen-
sive and low quality ones.
In our specific economic conditions we are trying to imple-
ment cost-effective approaches, including the use of so-called
multipurpose scintigraphy. The volume of diagnostic information
obtained with methods of multipurpose scintigraphy during sin-
gle investigation is comparable to that using a few routine meth-
ods of radionuclide investigation or other modalities. In particular,
the use of multipurpose scintigraphy with osteotropic 99m Tc-pyr-
photech (single investigation) enables the revealing of renal func-
tion changes, evaluation of anatomotopographic status of the kid-
ney, visualisation of primary retroperitoneal tumour in children,
tumour lesions in bones, formation of respective scintigraphic
patterns which effectively contribute to the differentiation of Wilms
tumour, neuroblastoma (including neuroblastoma involving the
kidney, main vessels and surrounding tissues), malignant lympho-
mas, abnormalities of kidney development and their combinations
with tumours. Multipurpose lymphotropic scintigraphies with 67
Ga-citrate and 99m Tc-pyrphotech were also developed and used.
The use of new algorithms of patient examination on the basis
of multipurpose scintigraphies and radioimmunoassay leads to a
decrease in volume, time, costs of study, burden irradiation.
We started activities towards the standardisation of methods
for radionuclide diagnosis and treatment according to the recom-
mendations of EANM and IAEA. In particular, the recommenda-
tions of EANM (Task Group on Irradiation Therapy) helped us in
the unification of thyroid cancer treatment in Ukraine.
Education. Previously the duration of education was very limited.
Now the education of NM specialists includes residency (1 year after
completion of the medical institute including variable duration of NM
practice «on-site»), postgraduate education (medical radiology in-
cluding 3 months of NM education), attestation cycles 1 month be-
fore examination (once every 5 years), periodic cycles of NM spe-
cialisation (3 months) or topic courses of education upgrading (1
month) at the Kiev Academy of Postgraduate Education.
Of course, the duration of education is not sufficient but the
situation in this field has somewhat improved.
Conclusion
We consider that the continuation of the above activities and im-
plementation of the advanced methods of radionuclide diagnosis
and treatment will enable the survival and development of NM in
Ukraine.
